Discover the PulmoRounds: Where Respiratory Expertise Meets Clinical Practice

Author : Sanofi

Editorial team

The Stockholm PulmoRounds event on August 27th brought together Sweden's leading respiratory specialists for an exceptional scientific exchange. Moderated by Dr. George Grantson, this prestigious gathering featured illuminating presentations on type 2 inflammation, with international authorities Prof. Dr. Alberto Papi and Prof. Dr. Frits Franssen delivering compelling insights on asthma and COPD management.

The dynamic Q&A sessions, both in-person and digital, demonstrated the critical relevance of these topics to today's clinical practice.

We've captured the essence of this knowledge exchange in 6 exclusive expert interviews, each addressing specific challenges in respiratory care.

Watch our National and International Speakers addressing key specific challenges in respiratory care

Professor Franssen

The importance of biomarkers and endotyping in COPD

Professor Franssen

The role of eosinophils (EOS) in COPD

Professor Franssen

The impact of exacerbations on disease progression

Professor Franssen

Change in COPD care in the next generation outside of biologics

Professor Papi

Evidence supporting the claim of disease modification in severe asthma

Professor Papi

The next generation of severe asthma care outside of biologics

International speakers

George Grantson

Dr. George Grantson

Allergimottagningen Varberg,
Sweden

Franssen

Prof. Dr. Frits Franssen

Head of Department of Respiratory Medicine at Maastricht UMC+,
The Netherlands

Prof. Dr. Frits Franssen (1973) is a respiratory physician and professor of personalized management of chronic obstructive pulmonary disease (COPD). He is medical head of the Department of Respiratory Medicine at Maastricht University Medical Center in Maastricht, the Netherlands. He is also a member of the Board of Directors of CIRO+, a center of expertise for patients with chronic respiratory diseases in Horn, the Netherlands. He was a member of the Lancet COPD Committee and is involved in several ATS/ERS task forces. He has co-authored more than 300 peer-reviewed English-language articles and currently supervises 14 PhD students. He is also deputy editor of Respirology and section editor of the Dutch Journal of Medicine (NTvG). In 2019, he was appointed a Fellow of the ERS.

Alberto

Prof. Dr. Alberto Papi

Professor of Respiratory Medicine at the University of Ferrara,
Italy

Alberto Papi is Professor of Respiratory Medicine at the University of Ferrara, Italy, and Director of the Respiratory Unit of the Department of CardioThoracic Medicine, S. Anna University Hospital, Ferrara, Italy.

Professor Papi trained in Respiratory Medicine at the University of Parma, and spent 4 years in the UK as a Clinical Research Fellow at the University of Southampton, where he is an Honorary Clinical Lecturer. In 2015, he was made a Fellow of the European Respiratory Society. He is Member of the GOLD Science Committee.

Professor Papi’s principal field of research is airway inflammation in asthma and COPD, its molecular mechanisms and pharmacological modulation. In his studies, he has taken particular interest in the role of respiratory viral infections in stable/exacerbated obstructive lung diseases, and the underlying molecular and immunological mechanisms. He has coordinated several studies, particularly in asthma and COPD, and he has given presentations at national and international meetings. He has published more than 600 articles in peer-reviewed journals (including NEJM, Lancet, Lancet Respiratory Medicine, AJRCCM), and several other publications in non-peer-reviewed journals. H Index 103.